Finoriq research workspace
AMARIN CORP PLC\UK (AMRN) Institutional Holdings & 13F Ownership
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization. Review AMRN institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
- Company
- AMARIN CORP PLC\UK (AMRN)
- Ticker
- AMRN
- Market Cap
- $285.8M
- Latest Price
- $13.63
- Industry
- Biotech & Pharma
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.